Am J Ophthalmol

1. NISSEN K, Kiilgaard JF, Fili M, Seregard S, et al
   Increasing Incidence of Posterior Uveal Melanoma in Scandinavia 1960-2022: A Tri-National Study.
   Am J Ophthalmol. 2025 Mar 5:S0002-9394(25)00115.
   

   >> Share

   
   

   
   Am J Pathol

2. HEISKANEN L, Nissinen L, Siljamaki E, Knuutila JS, et al
   C5aR1 Promotes Invasion, Metastasis and Poor Prognosis in Cutaneous Squamous Cell Carcinoma.
   Am J Pathol. 2025 Mar 6:S0002-9440(25)00073-2. doi: 10.1016/j.ajpath.2025.
   

   >> Share

   
   

   
   BMC Cancer

3. QIAN L, Cairong Z, Yongdong L, Quan L, et al
   Prognostic role of STMN1 expression and neoadjuvant therapy efficacy in breast cancer.
   BMC Cancer. 2025;25:453.
   

   >> Share

   
   
4. TERREL-POCCOMO MK, Santillan-Romero G, Quispe-Vicuna C, Ybaseta-Medina J, et al
   Trends in breast cancer mortality in Peru and its geographical areas from 2013 to 2022 and prediction until 2027.
   BMC Cancer. 2025;25:463.
   

   >> Share

   
   
5. ZHANG N, Shao X, Xu L, Zhu W, et al
   Three-dimensional turbo-spin-echo amide proton transfer-weighted and intravoxel incoherent motion imaging mri for triple-negative breast cancer: a comparison with molecular subtypes and histological grades.
   BMC Cancer. 2025;25:465.
   

   >> Share

   
   
6. BOUZID RS, Bouzid R, Labed H, Serhani I, et al
   Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers.
   BMC Cancer. 2025;25:454.
   

   >> Share

   
   
7. RAVINDRANATH KJ, Srinivasan H
   Deciphering the anti-neoplastic potential of Allium ascalonicum in averting the proliferation and epithelial-mesenchymal transition of triple-negative breast cancer through virtual docking and In Vitro approaches.
   BMC Cancer. 2025;25:414.
   

   >> Share

   
   
8. LIU X, Meng Q, Fan W, Ning L, et al
   The effects of intermittent fasting on anthropometric indices, glycemic profile, chemotherapy-related toxicity, and subjective perception in gynecological and breast cancer patients: a systematic review and meta-analysis.
   BMC Cancer. 2025;25:419.
   

   >> Share

   
   

   
   Br J Dermatol

9. ZHANG Q, Liu G, Jing L, Aghayants S, et al
   The Landscape of m6A RNA Methylation in Skin Diseases.
   Br J Dermatol. 2025 Mar 10:ljaf087. doi: 10.1093.
   

   >> Share

   
   
10. SU T, Yu Y, Su Z, Lu Y, et al
    Rapid improvements in Kaposi sarcoma with metformin: a report of two cases.
    Br J Dermatol. 2025 Mar 11:ljaf090. doi: 10.1093.
    

    >> Share

    
    
11. LI T, Tao R, Yang L, Wan Z, et al
    Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis.
    Br J Dermatol. 2025 Mar 12:ljaf095. doi: 10.1093.
    

    >> Share

    
    
12. MIRANDA BH, Shahid S, Correiro A, Zhang J, et al
    St Andrews Referral Delay in Skin Cancer (StARDISC): A study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.
    Br J Dermatol. 2025 Mar 13:ljaf097. doi: 10.1093.
    

    >> Share

    
    
13. NAKAMIZO S, Kabashima K
    Cutaneous Granulomas: Mechanisms, Cellular Interactions, and Therapeutic Insights.
    Br J Dermatol. 2025 Mar 13:ljaf096. doi: 10.1093.
    

    >> Share

    
    

    
    Cancer

14. RAYCHAUDHURI S, McLaughlin E, Pennell ML, Stefanick M, et al
    The relationship between cardiometabolic abnormalities and mortality in the Women's Health Initiative: A comparison of associations among women with cancer to women without cancer.
    Cancer. 2025;131:e35804.
    

    >> Share

    
    

    
    Cancer Lett

15. WANG Z, He K, Liu M, Lv W, et al
    Enhanced mitochondrial biogenesis facilitates the development of cutaneous squamous cell carcinoma.
    Cancer Lett. 2025 Mar 10:217623. doi: 10.1016/j.canlet.2025.217623.
    

    >> Share

    
    

    
    Cancer Res

16. DEY P, Brisken C
    Breaking the Rhythm: Harnessing the Menstrual Cycle for Better Chemotherapy.
    Cancer Res. 2025 Jan 29. doi: 10.1158/0008-5472.CAN-25-0335.
    

    >> Share

    
    
17. GAO L, Huang J, Xia J, Zhao P, et al
    SNHG17 Reprograms Energy Metabolism of Breast Cancer by Activating Mitochondrial DNAs Transcription.
    Cancer Res. 2025 Jan 22. doi: 10.1158/0008-5472.CAN-24-1271.
    

    >> Share

    
    
18. TAU S, Chamberlin MD, Yang H, Marotti JD, et al
    Oxidative Phosphorylation is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer.
    Cancer Res. 2025 Jan 9. doi: 10.1158/0008-5472.CAN-24-1204.
    

    >> Share

    
    

    
    Clin Exp Dermatol

19. HUANG X, Luo S, Zhan Y, Fu S, et al
    Second-intention Healing Combined with ALA-PDT in the Treatment of Periocular Basal Cell Carcinoma.
    Clin Exp Dermatol. 2025 Mar 10:llaf114. doi: 10.1093.
    

    >> Share

    
    
20. LI J, Jiang G
    Dupilumab for Atopic Dermatitis in Patients with Malignancies: A Case Report and Literature Review on Efficacy, Safety, and Potential Mechanisms.
    Clin Exp Dermatol. 2025 Mar 11:llaf117. doi: 10.1093.
    

    >> Share

    
    
21. BALI R, Chung JG, Thomas L, Hussain K, et al
    Comparing the number-needed-to-biopsy ratio for melanoma diagnosis for artificial intelligence as a medical device, teledermatology and face-to-face models of care.
    Clin Exp Dermatol. 2025 Mar 11:llaf120. doi: 10.1093.
    

    >> Share

    
    
22. FLEMING S, Carthy K, Granahan A, Byrne B, et al
    Skin Oncology.
    Clin Exp Dermatol. 2025 Mar 12:llaf108. doi: 10.1093.
    

    >> Share

    
    
23. CHUNG JG, Bali R, Thomas L, Denny J, et al
    Photography in Teledermatology: Comparing the clinical photographer, general practitioner and patient led model in skin cancers.
    Clin Exp Dermatol. 2025 Mar 13:llaf129. doi: 10.1093.
    

    >> Share

    
    
24. SAKUNCHOTPANIT G, Nayudu K, Chen R, Milosavljevic S, et al
    Representations of skin tone and sex in dermatology by generative artificial intelligence: a comparative study.
    Clin Exp Dermatol. 2025 Mar 13:llaf126. doi: 10.1093.
    

    >> Share

    
    

    
    Int J Dermatol

25. VAN DALEN SCM, Stein JWJ, Bruurmijn T, Foster ML, et al
    Neutrophil Extracellular Traps Are Widely Distributed Across Lesional and Perilesional Hidradenitis Suppurativa Skin, and Elevated Serum NET Markers Associate With Moderate to Severe HS Disease.
    Int J Dermatol. 2025 Mar 13. doi: 10.1111/ijd.17706.
    

    >> Share

    
    
26. KASSANG P, Akakpo SA, Teclessou JN, Gnosike P, et al
    Skin Cancers in People With Albinism: An Overview and Review of Literature.
    Int J Dermatol. 2025 Mar 10. doi: 10.1111/ijd.17719.
    

    >> Share

    
    

    
    J Dermatol

27. TORII H, Morita A, Yamamoto C, Dong J, et al
    Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance.
    J Dermatol. 2025 Mar 13. doi: 10.1111/1346-8138.17695.
    

    >> Share

    
    
28. MORITA A, Imafuku S, Tada Y, Okubo Y, et al
    Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO-1, PSO-4, and LTE trials.
    J Dermatol. 2025 Mar 11. doi: 10.1111/1346-8138.17685.
    

    >> Share

    
    

    
    J Invest Dermatol

29. YUE L, Pang B, Li G, Zhang C, et al
    Endothelial Piezo1 mediates barrier dysfunction and NLRP3 inflammasomes activation in psoriasis.
    J Invest Dermatol. 2025 Mar 5:S0022-202X(25)00303.
    

    >> Share

    
    
30. LANE M, Aubert A, Prudova A, Liu F, et al
    Extracellular Granzyme B mediates degradation of Collagen XVII in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    J Invest Dermatol. 2025 Mar 6:S0022-202X(25)00306.
    

    >> Share

    
    
31. LEBTIG M, Peschel A, Kretschmer D
    Role of Formyl Peptide Receptor 2 and Toll-Like Receptor 2 in Skin Barrier Function and Atopic Dermatitis.
    J Invest Dermatol. 2025 Mar 9:S0022-202X(25)00100.
    

    >> Share

    
    
32. WANG Y, Yin H, Li Z, Wu H, et al
    Blood transcriptome signature as indicator and predictor for efficacy of abrocitinib in treatment of atopic dermatitis.
    J Invest Dermatol. 2025 Mar 7:S0022-202X(25)00311.
    

    >> Share

    
    
33. SCOTT RW
    The Beauty of Fibroblasts Is Several Skin Layers Deep and Much Deeper.
    J Invest Dermatol. 2025 Mar 10:S0022-202X(25)00126.
    

    >> Share

    
    
34. WONG ZY, Ou KQ, Wong ZN, Faderani R, et al
    Comment on "Does Sex Matter? Temporal Analyses of Melanoma Trends among Men and Women Suggest Etiologic Heterogeneity.".
    J Invest Dermatol. 2025 Feb 4:S0022-202X(25)00005.
    

    >> Share

    
    

    
    J Laryngol Otol

35. PAULOSE AA, Michael RC, Ramalingam N, Riju J, et al
    A matched pair analysis of outcomes after stapler-assisted pharyngeal closure following laryngectomy.
    J Laryngol Otol. 2025;139:78-84.
    

    >> Share

    
    

    
    Mycoses

36. BARBOSA LSP, Ely MM, Salome TM, de Almeida de Souza GH, et al
    Fungal Infections Associated With TNF-Inhibitors: A 20-Year of a Systematic Review Fungal Infections and TNF-Inhibitors.
    Mycoses. 2025;68:e70040.
    

    >> Share

    
    

    
    N Engl J Med

37. REIMER T, Stachs A, Veselinovic K, Kuhn T, et al
    Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial.
    N Engl J Med. 2024 Dec 12. doi: 10.1056/NEJMoa2412063.
    

    >> Share

    
    
38. PANDYA A, Horissian M
    Linear IgA Bullous Dermatosis of Childhood.
    N Engl J Med. 2025;392:1120.
    

    >> Share

    
    
39. REGINA J, Waeber G
    Thin Skin in Cushing's Syndrome.
    N Engl J Med. 2025;392:e28.
    

    >> Share

    
    

    
    PLoS One

40. LE MN, Chen D, Smith KA, Tran DD, et al
    Microfluidic isolation and release of live disseminated breast tumor cells in bone marrow.
    PLoS One. 2025;20:e0319392.
    

    >> Share

    
    
41. MALLARI MA, Singh A, Shubella J, Khaliq W, et al
    Cancer screening prevalence and preference among hospitalized women with and without diabetes mellitus.
    PLoS One. 2025;20:e0319681.
    

    >> Share

    
    
42. RAHMANDOUST M, Abdolrahimi S
    Introducing carbon quantum dot-Capivasertib drug carrier complex for enhanced treatment of breast cancer.
    PLoS One. 2025;20:e0319206.
    

    >> Share

    
    
43. CHEN S, Cui X, Chen Y, Guo X, et al
    Biologic therapies for the treatment of large vessel vasculitis: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314566.
    

    >> Share

    
    
44. THOMAS J, Malla L, Shibwabo B
    Advances in analytical approaches for background parenchymal enhancement in predicting breast tumor response to neoadjuvant chemotherapy: A systematic review.
    PLoS One. 2025;20:e0317240.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share